OPLS-DA plot of GC-MS data (R 2 X: 0.717; R 2 Y: 0.948; Q 2 : 0.631); C: PCA plot of LC-MS data (R 2 X: 0.62; Q 2 : 0.53); D: OPLS-DA plot of LC-MS data (R 2 X: 0.737; R 2 Y: 0.878; Q 2 : 0.815). Table S1 . The peak areas and retention times of top 12 peaks in QC samples (GC-MS). Table S2 . The peak areas and retention times of top 12 peaks in QC samples (LC-MS). Table S3 . Identified metabolites and their relative levels in the control, model and LR groups. Figure S2 . Plots of PCA and OPLS-DA. A: PCA plot of GC-MS data (R 2 X: 0.774; Q 2 : 0.603); B:
OPLS-DA plot of GC-MS data (R 2 X: 0.717; R 2 Y: 0.948; Q 2 : 0.631); C: PCA plot of LC-MS data (R 2 X: 0.62; Q 2 : 0.53); D: OPLS-DA plot of LC-MS data (R 2 X: 0.737; R 2 Y: 0.878; Q 2 : 0.815). Figure S4 . Result of metabolic pathway analysis through MetPA software. The hypothesis test for the difference between two means was conducted through t-test. *: p < 0.05; **: p < 0.01; ***: p < 0.001.
